Deep Vein Thrombosis, Pulmonary Embolism, and Primary Pulmonary Hypertension

  • Samuel Z. Goldhaber
  • Joseph F. Polak


Deep venous thrombosis and pulmonary embolism constitute a cardiovascular illness, venous thromboembolism, and represent an often-unrecognized disease that causes surprisingly frequently disability and loss of life. Overshadowed by acute coronary syndromes, which are more likely to present suddenly with dramatic onset of chest pain, nausea, and diaphoresis, venous thromboembolism is insidious, subtle, and easily overlooked. The consequences of a missed diagnosis of venous thromboembolism can be devastating. The disease, like coronary heart disease, may cause sudden cardiovascular collapse and death due to massive pulmonary embolism. More common, though, is the development of long-term dyspnea on exertion due to chronic pulmonary hypertension, or permanent calf swelling and leg aching due to chronic venous insufficiency.


Pulmonary Embolism Right Ventricle Deep Vein Thrombosis Deep Venous Thrombosis Venous Thromboembolism 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Joffe HV, Goldhaber SZ: Laboratory thrombophilias and venous thromboembolism. Vasc Med,In press.Google Scholar
  2. 2.
    Gelfand EV, Piazza G, Goldhaber SZ: Venous thromboembolism guidebook. Critical Pathways in Cardiology 2002, 1: 26–43.PubMedCrossRefGoogle Scholar
  3. Hyers TM, Agnelli G, Hull RD, et al.: Antithrombotic therapy for venous thromboembolic disease. Chest 2001,119:176S–206S.Google Scholar
  4. 4.
    Breddin HK, Hach-Wunderle V, Nakov R, Kakkar VV: Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis. N Engl J Med 2001, 344: 626–631.PubMedCrossRefGoogle Scholar
  5. 5.
    Deitcher SR, Carman TL: Heparin-induced thrombocytopenia: natural history, diagnosis, and management. Vasc Med 2001, 6: 113–119.PubMedGoogle Scholar
  6. 6.
    Warkentin TE, Kelton JG: Temporal aspects of heparin-induced thrombocytopenia. N Engl J Med 2001, 344: 1286–1292.PubMedCrossRefGoogle Scholar
  7. 7.
    Warkentin TE, Kelton JG: Delayed-onset heparin-induced thrombocytopenia and thrombosis. Ann Intern Med 2001, 135: 502–506.PubMedCrossRefGoogle Scholar
  8. 8.
    Rice L, Attisha WK, Drexler A, Francis JL: Delayed-onset heparin-induced thrombocytopenia. Ann Intern Med 2002, 136: 210–215.PubMedCrossRefGoogle Scholar
  9. Lewis BE, Wallis DE, Berkowitz SD, et al.: Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia. Circulation 2001,103:1838–1843.Google Scholar
  10. Greinacher A, Volpel H, Janssens U, et al.: Recombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia: a prospective study. Circulation 1999, 99:73–80.Google Scholar
  11. 11.
    Daniel KR, Courtney DM, Kline JA: Assessment of cardiac stress from massive pulmonary embolism with 12-lead ECG. Chest 2001, 120: 474–481.PubMedCrossRefGoogle Scholar
  12. Wicki J, Perrier A, Perneger TV, et al.: Predicting adverse outcome in patients with acute pulmonary embolism: a risk score. Thromb Haemost 2000, 84:548–552.Google Scholar
  13. Meyer T, Binder L, Hruska N, et al.: Cardiac troponin I elevation in acute pulmonary embolism is associated with right ventricular dysfunction. J Am Coll Cardiol 2000, 36:1632–1636.Google Scholar
  14. Giannitsis E, Muller-Bardorff M, Kurowski V, et al.: Independent prognostic value of cardiac troponin T in patients with confirmed pulmonary embolism. Circulation 2000,102:211–217.Google Scholar
  15. 15.
    Goldhaber SZ: Echocardiography in the management of pulmonary embolism. Ann Intern Med 2002, 136: 691–700.PubMedCrossRefGoogle Scholar
  16. 16.
    Arcasoy SM, Kreit JW: Thrombolytic therapy of pulmonary embolism: a comprehensive review of current evidence. Chest 1999, 115: 1695–1707.PubMedCrossRefGoogle Scholar
  17. 17.
    Wood KE: Major pulmonary embolism: review of a pathophysiologic approach to the golden hour of hemodynamically significant pulmonary embolism. Chest 2002, 121: 877–905.PubMedCrossRefGoogle Scholar
  18. 18.
    Goldhaber SZ, Visani L, De Rosa M: Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999, 353: 1386–1389.PubMedCrossRefGoogle Scholar
  19. Hamel E, Pacouret G, Vincentelli D, et al.: Thrombolysis or heparin therapy in massive pulmonary embolism with right ventricular dilation: results from a 128-patient monocenter registry. Chest 2001, 120:120–125.Google Scholar
  20. 20.
    Feldman JP, Goldhaber SZ: The management of massive pulmonary embolism. In Thrombosis and Thromboembolism. Edited by Goldhaber SZ, Ridker PM. New York: Marcel Dekker; 2002: 235–245.Google Scholar
  21. 21.
    Goldhaber SZ: Thrombolysis in pulmonary embolism. In Thrombosis and Thromboembolism. Edited by Goldhaber SZ, Ridker PM. New York: Marcel Dekker; 2002: 247–259.Google Scholar
  22. 22.
    Sharma GV, Folland ED, McIntyre KM, Sasahara AA: Long-term benefit of thrombolytic therapy in patients with pulmonary embolism. Vasc Med 2000, 5: 91–95.PubMedGoogle Scholar
  23. 23.
    Goldhaber SZ: Thrombolysis in pulmonary embolism: a debatable indication. Thromb Haemost 2001, 86: 444–451.PubMedGoogle Scholar
  24. 24.
    Goldhaber SZ: Thrombolysis in pulmonary embolism: a large-scale clinical trial is overdue. Circulation 2001, 104: 2876–2878.PubMedGoogle Scholar
  25. 25.
    Goldhaber SZ: Integration of catheter thrombectomy into our armamentarium to treat acute pulmonary embolism. Chest 1998, 114: 1237–1238.PubMedCrossRefGoogle Scholar
  26. 26.
    Fava M, Loyola S, Huete I: Massive pulmonary embolism: treatment with the hydrolyser thrombectomy catheter. J Vasc Intery Radiol 2000, 11: 1159–1164.CrossRefGoogle Scholar
  27. De Gregorio MA, Gimeno MJ, Mainar A, et al.: Mechanical and enzymatic thrombolysis for massive pulmonary embolism. J Vasc Intery Radiol 2002,13:163–169.Google Scholar
  28. Decousus H, Leizorovicz A, Parent F, et al.: A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis: prevention du Risque d’Embolie Pulmonaire par Interruption Cave Study Group. N Engl I Med 1998, 338:409–415.Google Scholar
  29. Athanasoulis CA, Kaufman JA, Halpern EF, et al.: Inferior vena caval filters: review of a 26-year single-center clinical experience. Radiology 2000, 216:54–66.Google Scholar
  30. 30.
    White RH, Zhou H, Kim J, Romano PS: A population-based study of the effectiveness of inferior vena cava filter use among patients with venous thromboembolism. Arch Intern Med 2000, 160: 2033–2041.PubMedCrossRefGoogle Scholar
  31. 31.
    Aklog L, Williams CS, Byrne JG, Goldhaber SZ: Acute pulmonary embolectomy: a contemporary approach. Circulation 2002, 105: 1416–1419.PubMedCrossRefGoogle Scholar
  32. 32.
    Fedullo PF, Auger WR, Kerr KM, Rubin LJ: Chronic thromboembolic pulmonary hypertension. N Engl J Med 2001, 345: 1465–1472.PubMedCrossRefGoogle Scholar
  33. Feinstein JA, Goldhaber SZ, Lock JE, et al.: Balloon pulmonary angioplasty for treatment of chronic thromboembolic pulmonary hypertension. Circulation 2001, 103:10–13.Google Scholar
  34. 34.
    Gaine SP, Rubin LJ: Primary pulmonary hypertension. Lancet 1998, 352: 719–725.PubMedCrossRefGoogle Scholar
  35. 35.
    Raymond RJ, Hinderliter AL, Willis PW, et al.: Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension. J Am Coll Cardiol 2002, 39:1214–1219.Google Scholar
  36. 36.
    Rubin LJ, Badesch DB, Barst RJ, et al.: Bosentan therapy for pulmonary arterial hypertension. N Engl J Med 2002, 346:896–903.Google Scholar
  37. 37.
    Hoeper MM, Schwarze M, Ehlerding S, et al.: Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue. N Engl J Med 2000, 342:1866–1870.Google Scholar
  38. 38.
    Rimensberger PC, Spahr-Schopfer I, Berner M, et al.: Inhaled nitric oxide versus aerosolized iloprost in secondary pulmonary hypertension in children with congenital heart disease: vasodilator capacity and cellular mechanisms. Circulation 2001, 103:544–548.Google Scholar
  39. 39.
    Ghofrani HA, Wiedemann R, Rose F, et al.: Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension. Ann Intern Med 2002,136:515–522.Google Scholar

Copyright information

© Springer Science+Business Media New York 2003

Authors and Affiliations

  • Samuel Z. Goldhaber
  • Joseph F. Polak

There are no affiliations available

Personalised recommendations